Anti‐HCV for treatment of HCV‐positive psoriatic patients: A promising therapy. Issue 6 (5th November 2018)

• Record Type: Journal Article
• Authors: Abdelmaksoud, Ayman; Vestita, Michelangelo
• Is Part Of: Dermatologic therapy. Volume 31:Issue 6(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-11-05
• Subjects: direct‐acting antiviral agents -- HCV -- psoriasis; Skin -- Diseases -- Periodicals; Dermatology -- Periodicals; 616.5
• DOI: 10.1111/dth.12736
• Languages: English
• ISSNs: 1396-0296

Abstract

Abstract : Psoriasis is a chronic inflammatory disease that has been associated to liver disease, includinghepatitis C virus infection. TNF‐α is a key cytokine for both hepatitis C progression and psoriasis. HCV high‐prevalence countries are likely to show clear association of the two conditions. We reviewed the current literature on the effect of anti‐HCV therapy on the course of psoriasis in patient affected with both diseases.